2024 International Congress Archives - Page 168 of 181

GABA in the Basal Ganglia Tracks Motor Severity and Response to BoNT Treatment in Cervical Dystonia

C. Dintino, C. Groth, B. Berman (Richmond, USA)
GAD-Positive Versus GAD-Negative Stiff Person Syndrome: A Retrospective Study

W. Khan, M. Hamed, H. Ooi, H. Sarva, M. Salgado, D. Victor (Doha, Qatar)
Gait Analysis in the 6-Hydroxydopamine Hemiparkinson Rat Model with Deep Brain Stimulation in the Subthalamic nucleus

M. Statz, H. Weber, F. Plocksties, D. Timmermann, K. Budde-Sagert, S. Spors, H. Bathel, U. van Rienen, M. Fauser, A. Storch (Rostock, Germany)
Gait and turning during daily life across the spectrum of normal, prodromal, early and moderate Parkinson’s disease

M. Mancini, V. Shah, P. Burgos, P. Carlson-Kuhta, L. Talman, M. Lim, J. Quinn, F. Horak (Portland, USA)
Gait Digital Outcomes Exploration from Continuous Real-World Recordings in Parkinson’s Disease

M. Michaud, G. Parinello, E. Kluczka, C. Cluzeau, M-L. Brechemier, F. Bompaire, C. Tafani, M. Sallansonnet-Froment, T. Gidaro, L. Oudre, D. Ricard (Gif-Sur-Yvette, France)
Gaps in Diagnosing and Treating Tic Disorders in Latin America: A Survey of Healthcare Workers

D. Munoz, A. Medina (Santiago, Chile)
Gastrointestinal Dysbiosis and Clinical Outcomes in Parkinson’s Disease

K. Julio, A. Vakhtin, H. Lin, A. Birg, N. Hoffman, S. Nitschke, N. Shaff, E. Erhardt, A. Mayer, D. Sugar, G. Suarez Cedeno, A. Deligtisch, S. Pirio Richardson, S. Ryman (Albuquerque, USA)
Gathering Prodromal Participant Perspective on Receiving Personal Research Information

C. Destro, M. Mcguire Kuhl, J. Schulze, L. Heathers, T. Foroud, T. Tropea, B. Henry, J. Talarico, C. Stanley, E. Flagg (New York, USA)
GBA Mutation Profile in Parkinson’s Disease: Insights from a Movement Disorders Center in Brazil

F. Rolim, S. Lima, A. Verde, P. Matos, A. Marinho, F. Carvalho (Fortaleza, Brazil)
GBA1 deficiency differentially affects endolysosomal trafficking in neurons and astrocytes

S. Fish, A. Khera, J. Weiss, A. Park, R. Estes, S. Yu, L. Pallanck, J. Young, M. Davis (Seattle, USA)
Gender Differences Following Bilateral STN DBS Surgery in Parkinson’s Disease

E. Israel, I. Dustin, D. Ehrlich (Bethesda, USA)
Gender Differences in Physical Activity in Parkinson’s Disease

G. Vitek, M. Fullard (Aurora, USA)
Gender Disparities in Daytime Sleepiness Among Hispanic Individuals with Parkinson’s Disease: A Cross-Sectional Study

C. Rodriguez-Alarcon, D. Piana-Castillo, G. Faggioni-Sanchez, D. Bustamante-Mieles, C. Cevallos-Velasco, M. Barreiro-Guillén, R. Santibanez-Vasquez (Guayaquil, Ecuador)
Gender Disparities in Depressive Symptoms among Hispanic Parkinson’s Disease Patients: A Cross-Sectional Study

C. Rodriguez-Alarcon, D. Piana-Castillo, G. Faggioni-Sanchez, D. Bustamante-Mieles, C. Cevallos-Velasco, M. Barreiro-Guillén, R. Santibanez-Vasquez (Guayaquil, Ecuador)
Gender Disparities in Quality of Life Domains Among Hispanic Individuals with Parkinson’s Disease: A Comparative Analysis

D. Bustamante-Mieles, C. Rodriguez-Alarcon, D. Piana-Castillo, G. Faggioni-Sanchez, C. Cevallos-Velasco, M. Barreiro-Guillén, R. Santibanez-Vasquez (Guayaquil, Ecuador)
Gender specificity in AI-Based Screening Diagnostics of Parkinson’s Disease (Brainphone Project)

D. Khasanova, I. Khasanov, G. Ilina, Z. Zalyalova (Kazan, Russian Federation)
Gender-Based Differences in Sleep Quality Among Hispanic Parkinson’s Disease Patients

D. Piana-Castillo, C. Rodriguez-Alarcon, G. Faggioni-Sanchez, D. Bustamante-Mieles, C. Cevallos-Velasco, M. Barreiro-Guillén, R. Santibanez-Vasquez (Guayaquil, Ecuador)
Gender-related Cognitive Disparities in Hispanic Patients with Parkinson’s Disease: A Cross-Sectional Study

D. Piana-Castillo, C. Rodriguez-Alarcon, G. Faggioni-Sanchez, D. Bustamante-Mieles, C. Cevallos-Velasco, M. Barreiro-Guillén, R. Santibanez-Vasquez (Guayaquil, Ecuador)
Genetic Analysis of Mendelian mutations in A Large Chinese Early-onset and Familial Parkinson’s Disease

F. Xie, XS. Zheng, W. Luo (Hangzhou, China)
Genetic Analysis of UK Kindreds with Familial Tremor in The Global Parkinson’s Genetics Progam (GP2)

S. Jasaityte, R. Real, E. Stafford, R. Tilney, M. Fenn, A. Singleton, C. Blauwendraat, L. Lange, C. Klein, ZH. Fang, H. Morris, GP2. Genetics Program (London, United Kingdom)
Genetic Architecture Of Movement Disorder And Its Association With Consanguinity In Pashtoon Population

SHO. Rehman (Bannu, Kohat, Pakistan)
Genetic determinants of the progression of Lewy body pathology

L. Wu, AL. Gil, T. Georgiades, E. Stafford, K. Levine, M. Tan, A. Martinez Carrasco, D. Gveric, N. Wood, C. Smith, A. King, S. Love, A. Robinson, L. Parkinnen, C. Morris, J. Tunold, M. Nalls, C. Blauwendraat, A. Singleton, G. Halliday, C. Shepherd, S. Gentleman, T. Warner, Z. Jaunmuktane, L. Pihlstrom, J. Hardy, T. Lashley, R. Real, H. Morris (London, United Kingdom)
Genetic Heterogeneity in Chorea-Acanthocytosis Revealed by Varying VPS13A Mutations Within a Consanguineous Family

S. Alatrash, F. Farook, D. Nicholl (Newcastle-Under-Lyme, United Kingdom)
Genetic Migration Dynamics: Unraveling the Influence of Internal Migration on Huntington’s Disease Prevalence in the Amazonas State.

M. Della Coletta, C. Camargo, D. Brito, C. Fantin, G. Benevides, D. Cruz, M. Evangelista, F. Carvalho, M. Teles, D. Reis, E. Amaral, H. Teive (Manaus, Brazil)
Genetic Modifiers of Age at Onset for Parkinson’s Disease in Chinese Population

H. Pan, L. Liu, J. Guo, B. Tang, Y. Zhao (Changsha, China)
Genetic signatures stratify PwP into three subgroups with differing responses in two disease-modifying Phase 3 trials and indicate multiple disease biology pathways to Parkinson’s Disease

K. Hill, J. Cooper, J. Kozlowska, N. Olsen, R. Sultana, J. Surmeier, R. Wyse, N. Humphryes-Kirilov, A. Cooper (Sydney, Australia)
Genetic Study of polymorphism of cytokines in Parkinson’s disease.

S. Frikha, O. Ben Othmen, S. Fezai, A. Achouri, M. Ben Mahmoud, S. Fray, H. Jamoussi, M. Fredj, N. Ben Ali (Tunis, Tunisia)
Genetic Variant in the VPS16 Gene in a 44-year-old Patient with Generalized Dystonia

A. Sanguinetti, A. Tschopp, G. Ziegler, G. Povedano (Bueno Aires, Argentina)
Genetic Variants and Levodopa Response in Parkinson’s Disease: Insights from MAO-B and DAT1 Polymorphisms

S. Sarkar, A. Biswas, S. Ansari, S. Sengupta, S. Choudhury, R. Banerjee, S. Chatterjee, S. Dey, H. Kumar (Kolkata, India)
Genome-wide Assessment of Homozygosity in Parkinson’s Disease Across Diverse Ancestral Population

K. Step, C. Hernandez Astudillo, E. Eltaraifee, Z-H. Fang, A. Hernández-Medrano, P-J. Kung, M. Ostrožovičová, A. Zirra, I. Sarmiento, S. Bandres-Ciga (Cape Town, South Africa)
Genome-Wide Association Study revealing novel risk loci associated with Age at Onset of Parkinson’s Disease

YS. Hwang, SY. Jo, SH. Lee, KY. Park, SJ. Chung (Jeonju, Republic of Korea)
Genome-wide Survival Analysis Identified Association Between HS1BP3 and APOE loci and Dementia in Parkinson’s disease

S. Jo, J-H. Oh, J. Lee, S. Son, CO. Sung, SJ. Chung (Seoul, Republic of Korea)
Get Ready a mobile phone app a solution for patient engagement/remote management

R. Mills, M. Gibbs, N. Pavese, D. Ledingham, A. Hussain, A. Jenkins, C. Nicholson (Newcastle, United Kingdom)
Giant Aneurysm Causing Parkinsonism and REM Sleep Disorder

A. Falcone, I. Brum, F. Freua, E. Barbosa, R. Cury, J. Parmera (Sao Paulo, Brazil)
Global presence and penetrance of CSF1R-Related disorder

J. Dulski, M. Baker, S. Banks, M. Bayat, R. Bruffaerts, T. Chmiela, G. Cruz, C. Disserol, K. Fisher, N. Jainy, B. Kálmán, O. Kantarci, D. Maltsev, C. Middleton, G. Novotni, D. Plaseska-Karanfilska, S. Raskin, J. Souza, H. Teive, Z. Wszolek (Jacksonville, USA)
Global Trend of Parkinson’s Disease in 38 OECD Countries from 1990-2019: An Insight from the GBD 2019.

H. Desai, H. Chhayani, N. Brahmbhatt, J. Jobby, B. Desai, M. Lakkimsetti, P. Vemparala (Bhuj, India)
GNAO1-related Neurodevelopmental Disorder with Involuntary Movements Inducing a Dyskinetic Status

M. Silva, P. Lacerda, V. Maciel, K. Massruha, A. Alves, I. Ferreira, I. Brum, A. Santana, M. Sakuma, R. Cury, C. Gusmao (São Paulo, Brazil)
Goal Attainment and Ambulation With Increasing Doses of IncobotulinumtoxinA: A Post Hoc Analysis of the TOWER Study

D. Bensmail, K. Fheodoroff, A. Hanschmann, L. Nicolson, W. Clarke, M. Vacchelli, J. Wissel (Garches, France)
GPR30 agonists attenuate haloperidol-induced neurotoxicity in SH-SY5Y cells and adult zebrafish.

SHU. Upadhayay, PKB. Kumar (Baathinda, India)
GRoningen Early-PD Ambroxol Treatment (GREAT) Trial: A randomized, double-blind, placebo-controlled, single center trial with ambroxol in Parkinson patients with a GBA-mutation

O. Siemeling, S. Slingerland, S. V/d Zee, T. van Laar (Groningen, Netherlands)
Gut Microbial Metabolites and Future Risk of Parkinson’s Disease: A Metabolome-wide Association Study

Y. Zhao, Y. Lai, S. Darweesh, B. Bloem, L. Forsgren, J. Hansen, JM. Huerta, M. Guevara, C. Lill, G. Miller, S. Peters, R. Vermeulen (Utrecht, Netherlands)
Gut Microbiota May Alter Glucose Metabolism in Patients with Parkinson’s Disease

ST. Tsai, MK. Lu, CH. Tsai, Y. Aoh, ZL. Lai, YY. Hsu, DS. Chao, PR. Hsueh (Taichung, Taiwan)